Difficulty: Medium
Average Score: 86%
Practice
Which beta blocker is commonly used in the treatment of angina and post-myocardial infarction?
Correct answer
B
Rationale
In the treatment of angina and post-myocardial infarction, the beta blocker commonly used is Metoprolol (Option B). Metoprolol is a selective beta-1 receptor blocker, making it particularly effective in reducing heart rate and blood pressure, thereby decreasing the workload of the heart and oxygen demand, which is beneficial in angina and post-MI management.
Option A, Propranolol, is a non-selective beta blocker, affecting both beta-1 and beta-2 receptors. While it is used in various conditions, its non-selectivity can lead to more side effects compared to selective beta blockers like Metoprolol.
Option C, Atenolol, is another selective beta-1 blocker like Metoprolol, but it has a longer half-life and is less commonly used in current practice compared to Metoprolol.
Option D, Nebivolol, is a newer beta blocker with vasodilatory properties due to its effect on nitric oxide release. While it has benefits in certain conditions, it is not the first-line choice for angina or post-MI treatment.
Educationally, understanding the differences between beta blockers in terms of selectivity, pharmacokinetics, and additional properties like vasodilation is crucial for healthcare professionals to make informed decisions when selecting the appropriate medication for a specific patient based on their condition and individual factors. This knowledge ensures optimal patient care and treatment outcomes.
Option A, Propranolol, is a non-selective beta blocker, affecting both beta-1 and beta-2 receptors. While it is used in various conditions, its non-selectivity can lead to more side effects compared to selective beta blockers like Metoprolol.
Option C, Atenolol, is another selective beta-1 blocker like Metoprolol, but it has a longer half-life and is less commonly used in current practice compared to Metoprolol.
Option D, Nebivolol, is a newer beta blocker with vasodilatory properties due to its effect on nitric oxide release. While it has benefits in certain conditions, it is not the first-line choice for angina or post-MI treatment.
Educationally, understanding the differences between beta blockers in terms of selectivity, pharmacokinetics, and additional properties like vasodilation is crucial for healthcare professionals to make informed decisions when selecting the appropriate medication for a specific patient based on their condition and individual factors. This knowledge ensures optimal patient care and treatment outcomes.